Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2001
11/04/2001CA2346149A1 Photo-reactive benzocyclobutenones and polymers therefrom for self-photocuring, photo-crosslinking and photopatterning without catalysts
11/01/2001WO2001081567A2 Method for producing genomic libraries and genomic libraries produced therewith
11/01/2001WO2001081307A2 Triaryl cation antibiotics from environmental dna
11/01/2001WO2001081306A2 Azide cyclization-based synthesis and intermediates for spla2 inhibitors
11/01/2001WO2001081305A2 Methylation of indole compounds using dimethy carbonate
11/01/2001WO2001081303A1 Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders
11/01/2001WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
11/01/2001WO2001081274A1 Process for producing substituted aromatic compound
11/01/2001US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001US20010037031 By cyclization of alkynylaminoaromatic, possibly attached to carrier, in polar aprotic solvent with alkali metal compound; drug synthesis
11/01/2001CA2407489A1 Triaryl cation antibiotics from environmental dna
10/2001
10/31/2001EP1149118A1 Method of producing derivatized polymers
10/31/2001EP1149092A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/31/2001EP1149078A1 Selective 5-ht 6? receptor ligands
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP1148783A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
10/31/2001EP0929543B1 Herbicidal composition
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320037A Antiviral indoleoxoacetyl piperazine derivatives
10/31/2001CN1319599A Process for preparing imidazolinone
10/31/2001CN1073993C Process for preparing bis (ether anhybrides) using alkylamine derivaed bismides having low melting temperatures
10/31/2001CN1073990C Process for preparing (inner) N-alkylimida
10/31/2001CN1073989C Synthesis process of N-hydroxyl phthalimide
10/30/2001US6310217 Antiinflammatory and analgesic agents
10/30/2001US6310216 Special 3-azabicyclo[3.1.0]hexanes, method for producing and modifying the same, and their use
10/30/2001US6310209 Synthesis of CC-1065/duocarmycin analogs
10/30/2001US6310208 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines
10/30/2001US6310178 Ureins derived from α, ω-diamino acids and process for their preparation
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310086 Indole derivatives and medicinal compositions containing the same
10/30/2001US6310074 Substituted dimeric compounds
10/30/2001US6310068 Benzonitriles and benzofluorides
10/30/2001US6310066 1-(4-chloro-phenoxy)-3-(4-(1h-indol-4-yl)-piperazin-1-yl)-propan-2-ol for example
10/30/2001US6310057 α-ketoamide multicatalytic protease inhibitors
10/30/2001US6310050 Therapeutic use of compounds with β3-agonist activity
10/30/2001CA2074723C Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
10/30/2001CA2048931C Carbamoyl-1-(pyridinylalkyl)-1h-indoles, indolines and related analogs
10/30/2001CA2048027C 3-arylindole and 3-arylindazole derivatives
10/25/2001WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001WO2001079169A2 Prostaglandin d2 receptor antagonists
10/25/2001WO2001079164A2 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001WO2001078697A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001WO2001078654A2 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001WO2001021588A3 Cycloalkyl bicycloheptene dicarboximides
10/25/2001US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents
10/25/2001US20010034359 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
10/25/2001US20010034344 Use of known agonists of the central cannabinoid receptor CB1
10/25/2001US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001CA2405248A1 Prostaglandin d2 receptor antagonists
10/25/2001CA2405233A1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001CA2403490A1 N-substituted dithiocarbamates for the treatment of biological disorders
10/24/2001EP1148047A2 Processes for preparing cyclic compounds
10/24/2001EP1147214A1 A novel method for designing protein kinase inhibitors
10/24/2001EP1147083A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
10/24/2001EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001EP1147074A1 Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
10/24/2001EP1146867A1 Antibacterial hydroxamic acid derivatives
10/24/2001CN1319094A Imidazolyl derivatives
10/24/2001CN1319090A Novel substuted indolimones, their preparation process and use as medicine
10/24/2001CN1318544A Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
10/24/2001CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
10/23/2001US6307087 Ligands for metals and improved metal-catalyzed processes based thereon
10/23/2001US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
10/23/2001US6306911 Enzyme inhibitors
10/23/2001US6306890 Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
10/23/2001US6306873 Substituted β-thiocarboxylic acids
10/23/2001US6306870 N-cinnamoyl derivatives of beta-carboline
10/23/2001US6306868 Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives
10/23/2001US6306852 Indole derivatives useful as endothelin receptor antagonists
10/23/2001US6306850 Chlorocyclopropyl-3-(2-chlorophenyl)-2-hydroxypropyl)2,4-dihyd ro-(1,2,4)-triazole-3-thione as fungicides
10/23/2001US6306840 Cell adhesion inhibitors
10/23/2001US6306607 Heterogeneous assay for pyrophosphate
10/23/2001US6306181 For dyeing human hair
10/23/2001CA2035397C Hexahydropyrrolo¬2,3-b|indole carbamates, -ureas, -amides and related compounds, a process for their preparation and their use as medicaments
10/18/2001WO2001077101A1 Chemical compounds
10/18/2001WO2001077077A1 Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
10/18/2001WO2001077075A2 Inhibitors of inflammation and reperfusion injury
10/18/2001WO2001077073A1 Cathepsin cysteine protease inhibitors
10/18/2001WO2001025196A3 Slurry preparation of bis(halophthalimides) and of polyether polymers
10/18/2001US20010031894 Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
10/18/2001CA2404630A1 Cathepsin cysteine protease inhibitors
10/18/2001CA2403012A1 Chemical compounds
10/17/2001EP1146041A1 Derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane and their use as inhibitors of the recapture of serotonine and of noradrenaline
10/17/2001EP1146040A2 Method of crystallizing 2-azabicyclo(2.2.1)hept-5-en-3-one
10/17/2001EP1146037A1 Process for the preparation of optically active amino alcohols
10/17/2001EP1144496A1 Polymeric stabilizers having low polydispersity
10/17/2001EP1144375A2 Synthesis of oligoketides
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1144305A1 NOVEL sPLA 2 INHIBITORS
10/17/2001EP1143974A1 Pharmaceutical compositions for alleviating discomfort
10/17/2001EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001EP1143960A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 458